[1]
Buchappa, G. et al. 2018. Scalable and Impurity-Free Process for Dasatinib: Src and BCR-Abl Inhibitor. Asian Journal of Chemistry. 30, 7 (May 2018), 1621–1628. DOI:https://doi.org/10.14233/ajchem.2018.21287.